2017
- Few people actually benefit from ‘breakthrough’ cancer immunotherapy. STAT
- PSA screening is still a bad deal. STAT
2016
Why a Cancer Moonshot is Unlikely to Give us a Cure. (Washington Post)
2015
- Five Years of Cancer Drug Approvals: Most Cost too Much and Give us Too Little. (RAPS invited rebuttal)
- Why Are Most Cancer Drugs So Expensive. (Guest of Allen Frances at the Huffington Post)
- Perspective on the Selective reporting of primary, secondary endpoints common in randomized oncology trials. (HemOnc Today)
- The Folly of Big Science Prizes. (The New York Times)
- When Doctors Rely on Promise Instead of Proof. (Baltimore Sun)
- Why Lisa Rosenbaum Gets Conflict of Interest Policies Wrong (Lown Institute)
2014
- Let's Take a Close Look at PARADIGM-HF (CardioExchange)
- And, the redacted discussion (CardioExchange)
2013
- President Bush's Cardiac Stent (Washington Post)
- How Should We Weight Conflicting Advice About our Health (Footnote1.com)
2012
- Clinical Researchers Meet the Physician Scientists (Kevin MD)
- Work Hour Reform is a Moral Imperative (Kevin MD)